GUGGENHEIM ENHANCED EQUITY STRATEGY FD COM Stock (NASDAQ: GGE)

GUGGENHEIM ENHANCED EQUITY STRATEGY FD COM Stock (NASDAQ:GGE), Trade Ideas

Guggenheim Enhanced Equity Strategy Fund

NYSE

Green Giant

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AFRM

AMCX

BILL

BTAI

BTTR

CENT

CLSK

CNTA

DOOR

EGAN

EMKR

EXPE

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IBEX

IGMS

ILAG

ILMN

Intelligent Bio Solutions Inc. - Common Stock

INBS

IREN

LTRX

MLGO

MTRX

NGVC

NSTG

OCUL

PINS

PLCE

RNLX

SHCO

STRM

SUNW

SYBX

TCBP

TERN

TTWO

VIRC

ZJYL

Shares of  Take-Two Interactive Software, Inc.  (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Pre-Market Outlook

EGOX

SPGC

Shares of  Cloudflare, Inc. (NYSE: NET) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and 

Why Cloudflare Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

AEHR

AWIN

ELEV

GRTX

HRYU

ICCT

ISRG

MVST

NEXI

PSMT

ROMA

TGTX

WLDS

XCUR

ZCAR

Shares of  Aehr Test Systems (NASDAQ: AEHR) shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance.

The company said revenue will likely be impacted by an anticipated delay in the timing of new orders from current and new customers.

Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket

GUGGENHEIM ENHANCED EQUITY STRATEGY FD COM

Green Giant Inc

Golden Grain Energy

Shares of Take-Two Interactive Software, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttwo#NASDAQ">TTWO</a>) fell sharply during Friday&rsquo;s session following third-quarter results.
Take-Two reported third-quarter total net bookings of $1.34 billion, down 3% year-over-year. The company also revised its 2024 net bookings forecast to $5.25 billion and $5.3 billion, down from $5.45 billion and $5.55 billion earlier.
Take-Two Interactive Software shares dipped 8.8% to $154.69 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Sunworks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sunw#NASDAQ">SUNW</a>) shares jumped 267% to $0.1990. Sunworks and three subsidiaries recently made the decision to cease operations and filed for Chapter 7 bankruptcy in the United States Bankruptcy Court for the District of Delaware.</li>
<li>TOP Financial Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/top#NASDAQ">TOP</a>) gained 87.55% to $6.13.</li>
<li>NanoString Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nstg#NASDAQ">NSTG</a>) shares climbed 66% to $0.1932 after the company disclosed completion of financing to support restructuring process.</li>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) jumped 47.3% to $4.24 following second-quarter results.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares climbed 46% to $1.6099 after jumping over 16% on Thursday.</li>
<li>Intelligent Living Application Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilag#NASDAQ">ILAG</a>) gained 45.5% to $0.6851 after surging around 24% on Thursday.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) shares rose 44.4% to $0.0535 after gaining 25% on Thursday.</li>
<li>Better Choice Company Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bttr#NYSE">BTTR</a>) gained 35% to $0.2379. Better Choice acquired Aimia Pet Healthco.</li>
<li>Masonite International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/door#NYSE">DOOR</a>) surged 34.5% to $129.99 after Owens Corning announced it will acquire the company for $3.9 billion.</li>
<li>Cloudflare, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/net#NYSE">NET</a>) rose 23.5% to $111.49 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) shares gained 22% to $12.81 after the company reported a year-over-year increase in first-quarter GAAP EPS and better-than-expected sales results.</li>
<li>Centessa Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnta#NASDAQ">CNTA</a>) climbed 20.5% to $8.99. Centessa Pharmaceuticals will present additional 52-weeks continuous treatment data from third year ongoing Phase 2a study of SerpinPC for treatment of hemophilia at 17th Annual Congress of European Association for Haemophilia and Allied Disorders.</li>
<li>IGM Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igms#NASDAQ">IGMS</a>) gained 19.2% to $15.44.</li>
<li>Streamline Health Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/strm#NASDAQ">STRM</a>) rose 18.8% to $0.4814.</li>
<li>Natural Grocers by Vitamin Cottage, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ngvc#NYSE">NGVC</a>) gained 18.2% to $17.51 following quarterly results.</li>
<li>Soho House &amp; Co Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shco#NYSE">SHCO</a>) rose 15.7% to $5.79. Soho House announced its board evaluated certain strategic transactions in the fall of 2023.</li>
<li>Iris Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) gained 13.1% to $5.77.</li>
<li>Matrix Service Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtrx#NASDAQ">MTRX</a>) rose 13.1% to $12.82.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tern#NASDAQ">TERN</a>) gained 12.6% to $7.07.</li>
<li>Central Garden &amp; Pet Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cent#NASDAQ">CENT</a>) rose 10.4% to $43.03. Central Garden &amp; Pet reported better-than-expected first-quarter financial results.</li>
<li>Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) gained 10.2% to $117.18 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) rose 8.2% to $5.44. B of A Securities analyst Tazeen Ahmad initiated coverage on Ocular Therapeutix with a Buy rating and announced a price target of $15.</li>
<li>Mueller Water Products, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mwa#NYSE">MWA</a>) gained 8% to $14.99 following upbeat results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Synlogic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sybx#NASDAQ">SYBX</a>) fell 53.3% to $1.61 after the company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more than 90%.</li>
<li>The Children&#39;s Place, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plce#NASDAQ">PLCE</a>) shares fell 52.7% to $9.34 after the company said it expects fourth-quarter net sales to be roughly $454 million to $456 million, versus its prior guidance of $460 million to $465 million, and below the estimate of $462.88 million.</li>
<li>BioXcel Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btai#NASDAQ">BTAI</a>) fell 33.7% to $2.4882 after the company announced a proposed public offering.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) declined 33.5% to $8.62.</li>
<li>EMCORE Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/emkr#NASDAQ">EMKR</a>) fell 32% to $0.4275 after posting weak quarterly results.</li>
<li>MicroAlgo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlgo#NASDAQ">MLGO</a>) declined 31% to $0.7172.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) shares fell 30% to $0.3791 after climbing over 96% on Thursday.</li>
<li>Lantronix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltrx#NASDAQ">LTRX</a>) fell 28.8% to $4.1350 following weak sales.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares declined 27.4% to $20.81 after jumping over 59% on Thursday. The company announced it planned to join the Communications Industry Association. HOLO intends to join the Communications Industry Association to foster information technology innovation.</li>
<li>eGain Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egan#NASDAQ">EGAN</a>) fell 24.4% to $5.77 following second-quarter results.</li>
<li>AMC Networks Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amcx#NASDAQ">AMCX</a>) declined 19.1% to $13.78 following weak earnings.</li>
<li>Virco Mfg. Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virc#NASDAQ">VIRC</a>) dipped 18.6% to $9.48.</li>
<li>Expedia Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/expe#NASDAQ">EXPE</a>) declined 17.6% to $131.38 after the company reported fourth-quarter financial results and named Ariane Gorin as CEO.</li>
<li>Adlai Nortye Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anl#NASDAQ">ANL</a>) fell 12.3% to $7.50.</li>
<li>Newell Brands Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwl#NASDAQ">NWL</a>) declined 11.8% to $7.45 following quarterly results.</li>
<li>Pinterest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pins#NYSE">PINS</a>) shares declined 11.4% to $36.07. Pinterest reported upbeat earnings for its fourth quarter, while sales missed estimates. The company said it sees first-quarter revenue in the range of $690 million to $705 million versus estimates of $702.36 million.</li>
<li>BILL Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bill#NYSE">BILL</a>) fell 11% to $67.40 following quarterly results.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) shares fell 10.6% to $43.98 after the company reported second-quarter financial results.</li>
<li>IBEX Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibex#NASDAQ">IBEX</a>) fell 10.2% to $15.61.</li>
<li>Sensient Technologies Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sxt#NYSE">SXT</a>) fell 9.6% to $56.62 following weak earnings.</li>
<li>Owens Corning (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oc#NYSE">OC</a>) fell 6.9% to $148.43 after the company announced an agreement to acquire Masonite for $3.9 billion.</li>
<li>Magna International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mga#NYSE">MGA</a>) declined 6.5% to $54.89 after the company reported mixed quarterly results.</li>
<li>Illumina, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilmn#NASDAQ">ILMN</a>) shares declined 2.7% to $139.45 following fourth-quarter results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37034937/bitcoin-surpasses-47-000-thorchain-emerges-as-top-gainer"> Bitcoin Tops $47,000; THORChain Emerges As Top Gainer </a>

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Cloudflare, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/net#NYSE">NET</a>) rose sharply in today&rsquo;s pre-market trading after the company reported better-than-expected fourth-quarter financial results and <a href="https://www.benzinga.com/news/earnings/24/02/37020695/cloudflare-q4-earnings-revenue-beat-eps-beat-strong-guidance-robust-momentum-and-more">issued first-quarter guidance</a>.
Revenue came in at $362.47 million, beating estimates of $353.1 million. The company posted earnings of 15 cents per share, topping estimates of 12 cents per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Cloudflare expects full-year 2024 revenue of $1.648 billion and $1.652 billion versus estimates of $1.65 billion. The company sees full-year earnings in the range of 58 cents to 59 cents per share versus estimates of 56 cents per share.
Cloudflare shares surged 25.9% to $113.70 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) gained 164% to $0.66 in pre-market trading.</li>
<li>Intelligent Living Application Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilag#NASDAQ">ILAG</a>) gained 110.5% to $0.9897 in pre-market trading after surging around 24% on Thursday.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares jumped 49.1% to $1.64 in pre-market trading after jumping over 16% on Thursday.</li>
<li>Sunworks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sunw#NASDAQ">SUNW</a>) shares rose 30.3% to $0.0709 in pre-market trading. Sunworks and three subsidiaries recently made the decision to cease operations and filed for Chapter 7 bankruptcy in the United States Bankruptcy Court for the District of Delaware.</li>
<li>Cheche Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccg#NASDAQ">CCG</a>) shares rose 26% to $4.41 in pre-market trading after falling around 6% on Thursday.</li>
<li>Sacks Parente Golf, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spgc#NASDAQ">SPGC</a>) shares rose 24.8% to $0.96 in pre-market trading.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) shares gained 21.9% to $12.80 in pre-market trading after the company reported a year-over-year increase in first-quarter GAAP EPS and better-than-expected sales results.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) shares rose 21.4% to $0.0449 in pre-market trading after gaining 25% on Thursday.</li>
<li>Centrus Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/leu#NYSE">LEU</a>) shares gained 12.6% to $52.40 in pre-market trading following upbeat quarterly results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Synlogic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sybx#NASDAQ">SYBX</a>) shares dipped 52.2% to $1.65 in pre-market trading after the company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more than 90%.</li>
<li>BioXcel Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btai#NASDAQ">BTAI</a>) shares declined 36.3% to $2.39 in pre-market trading after the company announced a proposed public offering.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) shares fell 22.4% to $0.42 in pre-market trading after climbing over 96% on Thursday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares declined 22.4% to $22.26 in pre-market trading after jumping over 59% on Thursday. The company announced it planned to join the Communications Industry Association. HOLO intends to join the Communications Industry Association to foster information technology innovation.</li>
<li>EMCORE Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/emkr#NASDAQ">EMKR</a>) fell 19.7% to $0.5050 in pre-market trading after posting weak quarterly results.</li>
<li>The Children&#39;s Place, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plce#NASDAQ">PLCE</a>) shares declined 17.5% to $16.30 in pre-market trading.</li>
<li>Expedia Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/expe#NASDAQ">EXPE</a>) declined 13.3% to $138.23 in pre-market trading after the company reported fourth-quarter financial results and named Ariane Gorin as CEO.</li>
<li>Pinterest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pins#NYSE">PINS</a>) shares declined 10.4% to $36.50 in pre-market trading. Pinterest reported upbeat earnings for its fourth quarter, while sales missed estimates. The company said it sees first-quarter revenue in the range of $690 million to $705 million versus estimates of $702.36 million.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) shares fell 10.4% to $44.11 in pre-market trading after the company reported second-quarter financial results.</li>
<li>Take-Two Interactive Software, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttwo#NASDAQ">TTWO</a>) fell 8.9% to $154.50 in pre-market trading. Take-Two reported third-quarter total net bookings of $1.34 billion, down 3% year-over-year. The company also revised its 2024 net bookings forecast to $5.25 billion and $5.3 billion, down from $5.45 billion and $5.55 billion earlier.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37026785/pinterest-pepsico-and-3-stocks-to-watch-heading-into-friday"> Pinterest, PepsiCo And 3 Stocks To Watch Heading Into Friday</a>

Shares of Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance.
The company said revenue will likely be impacted by an anticipated delay in the timing of new orders from current and new customers.
Aehr Test Systems shares dipped 15% to $18.99 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Exicure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xcur#NASDAQ">XCUR</a>) shares rose 35.5% to $0.84 in pre-market trading. Exicure was granted broad U.S. patent #11866700 for &quot;Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 Mrna (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer&#39;s).&quot;</li>
<li>iCoreConnect Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icct#NASDAQ">ICCT</a>) shares rose 32.3% to $1.72 in pre-market trading. iCoreConnect announced strategic acquisition of Verifi Dental.</li>
<li>Zoomcar Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcar#NASDAQ">ZCAR</a>) shares jumped 15.8% to $7.40 in pre-market trading after surging more than 60% on Tuesday.</li>
<li>Microvast Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvst#NASDAQ">MVST</a>) shares gained 13.8% to $1.40 in pre-market trading after falling 5% on Tuesday.</li>
<li>SMART Global Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgh#NASDAQ">SGH</a>) gained 10.7% to $20.45 in pre-market trading after the company posted better-than-expected earnings for its first quarter and announced approval of $75 million share repurchase authorization.</li>
<li>PriceSmart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psmt#NASDAQ">PSMT</a>) gained 10% to $80.20 in pre-market trading as the company reported better-than-expected earnings for its first quarter on Tuesday.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) surged 9.1% to $22.93 in pre-market trading. TG Therapeutics recently announced that it has entered into an agreement with Precision BioSciences to acquire a worldwide license to Precision&#39;s Azercabtagene Zapreleucel (azer-cel), an allogeneic CD19 CAR T cell therapy program for autoimmune diseases and all other non-oncology indications.</li>
<li>Hanryu Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hryu#NASDAQ">HRYU</a>) shares climbed 8.5% to $0.91 in pre-market trading after falling around 7% on Tuesday.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) shares rose 7.6% to $0.0440 in pre-market trading after declining around 5% on Tuesday.</li>
<li>Intuitive Surgical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/isrg#NASDAQ">ISRG</a>) gained 5.3% to $348.01 in pre-market trading. Intuitive Surgical said it sees preliminary revenue of $1.93 billion for the fourth quarter, versus market estimates of $1.87 billion.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Roma Green Finance Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roma#NASDAQ">ROMA</a>) shares fell 29.3% to $2.05 in pre-market trading after dipping over 27% on Tuesday. Roma Green Finance announced pricing of $12.3 million public offering of 2,449,943 of shares at price of $4.00 per share.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) shares fell 16.3% to $2.36 in pre-market trading after dipping 26% on Tuesday.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) shares fell 12.6% to $10.31 in pre-market trading after jumping over 55% on Tuesday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) fell 10.2% to $0.2672 in pre-market trading after gaining 22% on Tuesday.</li>
<li>Elevation Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elev#NASDAQ">ELEV</a>) shares fell 8.1% to $1.81 in pre-market trading after gaining around 9% on Tuesday. Elevation Oncology recently said that it plans to provide an update from its ongoing Phase 1 trial of EO-3021 in mid-2024, with additional data expected in the first half of 2025.</li>
<li>Galera Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grtx#NASDAQ">GRTX</a>) shares fell 7.4% to $0.1952 in pre-market trading after jumping 41% on Tuesday.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) fell 6.7% to $0.42 in pre-market trading.</li>
<li>AERWINS Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/awin#NASDAQ">AWIN</a>) shares declined 6.5% to $0.1230 in pre-market trading. AERWINS Technologies recently entered into a letter of intent to form an entity with Helicopter Technology.</li>
<li>Sasol Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssl#NYSE">SSL</a>) shares fell 4.7% to $9.28 in pre-market trading.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/01/36571422/citigroup-likely-to-report-lower-q4-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of"> Citigroup Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

Shares of Titan Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttnp#NASDAQ">TTNP</a>) rose sharply in today&rsquo;s pre-market trading session.
Titan Pharmaceuticals said its Board of Directors has approved a 1-for-20 reverse stock split.
Titan Pharmaceuticals shares jumped 15.2% to $0.38 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>China Green Agriculture, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cga#NYSE">CGA</a>) shares gained 173.2% to $5.19 in pre-market trading. On Dec. 27, China Green Agriculture entered into a stock purchase agreement with Zhibiao Pan for the acquisition of all outstanding stock of Lonestar Dream for a total consideration of $49 million.</li>
<li>FLJ Group Limited(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flj#NASDAQ">FLJ</a>) gained 94.8% to $2.63 in pre-market trading. FLJ Group completed $180 million cash purchase of Alpha Mind Technology and terminated equity acquisition agreement entered into with Lianlian Holdings Inc.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) rose 71% to $0.33 in pre-market trading after gaining 7% on Thursday.</li>
<li>cbdMD, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ycbd#NYSE">YCBD</a>) shares rose 27.8% to $1.01 in pre-market trading after gaining 11% on Thursday.</li>
<li>CN Energy Group. Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cney#NASDAQ">CNEY</a>) shares gained 19.7% to $0.0720 in pre-market trading after gaining around 20% on Thursday.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) shares rose 14% to $0.0595 in pre-market trading. Green Giant recently announced pricing of public offering.</li>
<li>Genius Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gns#NYSE">GNS</a>) shares gained 11.4% to $0.7686 in pre-market trading. Genius Group recently updated financial guidance for the financial year ending December 31, 2023.</li>
<li>Dunxin Financial Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxf#NYSE">DXF</a>) gained 11.3% to $0.38 in pre-market trading.</li>
<li>Visionary Education Technology Holdings Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gv#NASDAQ">GV</a>) shares climbed 10.2% to $0.23 in pre-market trading.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>flyExclusive Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/flyx#NYSE">FLYX</a>) shares fell 24.1% to $5.20 in pre-market trading after dipping over 42% on Thursday.</li>
<li>Cingulate Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cing#NASDAQ">CING</a>) shares fell 23.1% to $7.55 in pre-market trading. Cingulate shares jumped 146% on Thursday after the company announced it received guidance from the FDA regarding its clinical program for CTx-1301.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) shares fell 23.1% to $1.33 in pre-market trading after jumping over 100% on Thursday. Earlier in December SenesTech announced substantial initial orders for its Evolve Soft Bait product which controls pests through a nontoxic method of fertility control. The company also announced its entry into an exclusive distribution agreement with Fruit Tree Limited, a pest control company based in Hong Kong.</li>
<li>Banyan Acquisition Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/byn#NYSE">BYN</a>) shares fell 20.8% to $10.25 in pre-market trading after jumping 42% on Thursday.</li>
<li>Nova LifeStyle, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvfy#NASDAQ">NVFY</a>) fell 18.2% to $3.84 in pre-market trading after jumping 203% on Thursday.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) shares fell 17.3% to $9.51 in pre-market trading. Sidus Space shares surged 163% on Thursday amid increased volatility after the company highlighted its 2023 achievements which it says have laid the groundwork for an anticipated launch in Q1 2024.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) shares fell 17.2% to $4.30 in pre-market trading after jumping over 71% on Thursday. Ucommune recently regained compliance with Nasdaq minimum bid price requirement.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) shares fell 14.4% to $0.5315 in pre-market trading after adding around 5% on Thursday.</li>
<li>Bone Biologics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bblg#NASDAQ">BBLG</a>) shares fell 13.5% to $5.19 in pre-market trading after gaining 29% on Thursday. Bone Biologics&#39; stock recently effected a 1-for-8 reverse-split on Dec. 20, and the company also announced the closing of a direct offering of 1,139,063 shares of common stock at a purchase price of $0.64 per share on Nov. 20.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) fell 12.4% to $2.88 in pre-market trading. On Dec. 27, 2023, Datchat filed a certificate of change in Nevada to increase its authorized common stock from 18 million to 180 million shares.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/12/36410375/top-4-utilities-stocks-that-could-sink-your-portfolio-in-december"> Top 4 Utilities Stocks That Could Sink Your Portfolio In December </a>

ASST

BBLG

CING

CNEY

DATS

FLYX

Kintara Therapeutics, Inc. - Common Stock

KTRA

NVFY

SIDU

SNES

TTNP

YCBD

Why Titan Pharmaceuticals Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Shares of Despegar.com, Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/desp#NYSE">DESP</a>) rose sharply during Wednesday&rsquo;s session after the company raised its FY23 financial guidance.
The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.
Despegar.com shares gained 16.4% to $9.90 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Shattuck Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sttk#NASDAQ">STTK</a>) jumped 127.5% to $4.80 after the company announced initial topline dose-expansion data from its ongoing Phase 1A/B clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients.</li>
<li>ReShape Lifesciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rsls#NASDAQ">RSLS</a>) shares gained 63.8% to $0.4110 after the company announced it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.</li>
<li>C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) shares jumped 59% to $3.7199 after the company announced data from the CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Following the update, Stifel analyst Bradley Canino upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12.</li>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) shares gained 38.3% to $0.2016 after declining 9% on Tuesday.</li>
<li>Innovative International Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ioac#NASDAQ">IOAC</a>) shares rose 36% to $11.66.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) shares gained 26% to $1.1708 after surging 29% on Tuesday.</li>
<li>Nephros, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neph#NASDAQ">NEPH</a>) rose 23% to $3.16.</li>
<li>SciSparc Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprc#NASDAQ">SPRC</a>) gained 21.7% to $5.95 after the company announced results for MitoCareX Bio with its drug discovery platform.</li>
<li>Eos Energy Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eose#NASDAQ">EOSE</a>) rose 21% to $1.35. Eos Energy and Pine Gate Renewables announced partnership expansion with a minimum additional volume Of 500MWH.</li>
<li>Photronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plab#NASDAQ">PLAB</a>) gained 18.7% to $25.66 following fourth-quarter results.</li>
<li>Mynaric AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/myna#NASDAQ">MYNA</a>) shares surged 18.2% to $5.66 after the company received a $33 million order from Northrop Grumman.</li>
<li>QuantaSing Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qsg#NASDAQ">QSG</a>) rose 17.2% to $2.4380 following first-quarter results.</li>
<li>Professional Diversity Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipdn#NASDAQ">IPDN</a>) gained 16% to $2.8899.</li>
<li>Aurora Mobile Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jg#NASDAQ">JG</a>) shares gained 14% to $2.8254. Aurora Mobile said its subsidiary Wuhan SendCloud Technology Co., Ltd. has entered into a strategic partnership with Beijing Muhua Information Technology Co., Ltd.</li>
<li>ABM Industries Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>) surged 13.6% to $50.38 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>LQR House Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqr#NASDAQ">LQR</a>) rose 9.5% to $1.4126. LQR House announced its new marketing campaign for Soda Jerk.</li>
<li>Vertex Pharmaceuticals Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrtx#NASDAQ">VRTX</a>) gained 7.4% to $384.03 after the company announced results from its Phase 2 study of VX-548 for the treatment of painful diabetic peripheral neuropathy.</li>
<li>REV Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/revg#NYSE">REVG</a>) gained 7.3% to $18.31 following upbeat quarterly results.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) rose 6.3% to $51.96. Cal-Maine has temporarily ceased production at a facility in Kansas following an outbreak of avian influenza at the site.</li>
<li>Take-Two Interactive Software, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttwo#NASDAQ">TTWO</a>) shares rose 3.5% to $162.64. Take-Two will be added to the Nasdaq-100 Index, effective prior to market open on Monday, Dec. 18, 2023.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Hywin Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hyw#NASDAQ">HYW</a>) shares fell 46.6% to $3.0001.</li>
<li>Boqii Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bq#NYSE">BQ</a>) declined 33.3% to $0.6670.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcsa#NASDAQ">PCSA</a>) fell 32.2% to $0.5497 as the company announced outcomes from meeting with the FDA regarding the company&#39;s next Phase 2 study supporting the advancement of next generation capecitabine for cancer patients.</li>
<li>Loop Media, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lptv#NASDAQ">LPTV</a>) fell 28.3% to $0.9246 following fourth-quarter results.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) declined 27% to $0.1415. TC BioPharm announced plan to implement ADS ratio change.</li>
<li>SRIVARU Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svmh#NASDAQ">SVMH</a>) fell 25.5% to $0.3051.</li>
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/whlr#NASDAQ">WHLR</a>) fell 24.6% to $0.2637.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) fell 18.8% to $0.0690. Green Giant recently announced pricing of its public offering.</li>
<li>WANG &amp; LEE GROUP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlgs#NASDAQ">WLGS</a>) fell 16.2% to $0.46 after gaining 7% on Tuesday.</li>
<li>Blackboxstocks Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blbx#NASDAQ">BLBX</a>) fell 15.8% to $3.24. Blackboxstocks announced it executed a definitive agreement to acquire Evtec Aluminium Limited.</li>
<li>IN8bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inab#NASDAQ">INAB</a>) shares fell 10.8% to $1.46 after jumping 28% on Tuesday. IN8bio recently announced updated data from its Phase 1 investigator-sponsored trial of INB-100 in patients with hematologic malignancies.</li>
<li>Target Hospitality Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/th#NYSE">TH</a>) declined 11% to $9.74 as the company lowered its FY23 guidance.</li>
<li>Medifast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/med#NYSE">MED</a>) fell 9% to $68.66. LifeMD announced a strategic alliance with Medifast to offer transformative weight management solution.</li>
<li>Pfizer Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>) declined 8.8% to $26.07 after the company provided FY24 guidance.</li>
<li>JetBlue Airways Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jblu#NASDAQ">JBLU</a>) fell 6.2% to $5.20.</li>
<li>Southwest Airlines Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/luv#NYSE">LUV</a>) fell 6% to $28.51. Southwest Airlines sees fourth-quarter unit revenues to be down 9%-10% vs. prior view of down 9%-11%.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/12/36196130/dont-miss-these-3-high-yielding-dividend-stocks-in-health-care-sector-from-wall-streets-most-accurat"> Don&#39;t Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street&#39;s Most Accurate Analysts</a>

BLBX

CALM

CCCC

DESP

EOSE

INAB

IOAC

IPDN

JBLU

LPTV

MYNA

NEPH

NXTP

PCSA

PLAB

REVG

RSLS

SPRC

STTK

SVMH

VRTX

WHLR

WLGS

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday.
The Dow traded up 0.32% to 36,520.57 while the NASDAQ rose 0.46% to 14,498.23. The S&amp;P 500 also rose, gaining, 0.26% to 4,634.47.
Check This Out: <a href="https://www.benzinga.com/news/23/12/36192758/microsoft-u-s-bancorp-and-2-other-stocks-insiders-are-selling"> Microsoft, U.S. Bancorp And 2 Other Stocks Insiders Are Selling</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Materials shares rose by 0.5% on Tuesday.
In trading on Tuesday, energy shares fell by 1.7%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Johnson Controls International plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jci#NYSE">JCI</a>) reported weak results for its fourth quarter.
Johnson Controls reported fourth-quarter FY23 sales growth of 2.7% year-on-year to $6.91 billion (+2% organically), missing the consensus of $7.09 billion. Adjusted EPS of $1.05 (+6% Y/Y) below the consensus of $1.09, according to Benzinga Pro.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) shares shot up 64% to $6.25. Aditxt agreed to acquire Evofem Biosciences in consideration of the issuance of a combination of common stock and preferred stock and the assumption of certain senior indebtedness, having an aggregate amount of approximately $100 million.
Shares of C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) got a boost, surging 108% to $2.45. C4 Therapeutics entered into an exclusive license and collaboration agreement with Merck &amp; Co to develop degrader-antibody conjugates (DACs), an emerging modality designed to selectively target and neutralize disease-causing proteins in cancer cells.
Icosavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icvx#NASDAQ">ICVX</a>) shares were also up, gaining 48% to $15.49. AstraZeneca agreed to acquire Icosavax at $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Achieve Life Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/achv#NASDAQ">ACHV</a>) shares dropped 42% to $3.1350. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline. Oppenheimer maintained Achieve Life Sciences with an Outperform and lowered the price target from $21 to $18.
Shares of Oracle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/orcl#NYSE">ORCL</a>) were down 12% to $101.50. Oracle reported upbeat earnings for its second quarter, while sales missed estimates.
Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) was down, falling 44% to $0.0850 as the company announced pricing of public offering.
Also Check This Out:<a href="https://www.benzinga.com/news/23/12/36196130/dont-miss-these-3-high-yielding-dividend-stocks-in-health-care-sector-from-wall-streets-most-accurat"> Don&#39;t Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street&#39;s Most Accurate Analysts</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 4.1% to $68.37 while gold traded up 0.1% at $1,994.70.
Silver traded down 0.1% to $23.045 on Tuesday while copper rose 0.2% to $3.7880.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed lower today. The eurozone&rsquo;s STOXX 600 fell 0.21%, London&rsquo;s FTSE 100 fell 0.03% while Spain&rsquo;s IBEX 35 Index fell 0.78% The German DAX fell 0.02% French CAC 40 fell 0.11%, while Italy&rsquo;s FTSE MIB Index fell 0.28%.
The ZEW Indicator of Economic Sentiment for the Eurozone surged by 9.2 points to 23 in December, recording the strongest reading in ten months, while German ZEW Indicator of Economic Sentiment rose to 12.8 in December from 9.8 in November.
The number of job vacancies in the UK fell to 949,000 from September to November, while regular pay, excluding bonus payment in the UK, rose 7.3% year-over-year to GBP 620/week in the three months to October.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly higher on Tuesday, with Japan&rsquo;s Nikkei 225 gaining 0.16%, Hong Kong&rsquo;s Hang Seng Index gaining 1.07% and China&rsquo;s Shanghai Composite Index gaining 0.40%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell 0.54%.
Producer prices in Japan increased 0.3% year-over-year in November following a revised 0.9% rise in October.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NFIB Small Business Optimism Index declined for a fourth straight month to a reading of 90.6 in November.
The annual inflation rate in the U.S. eased to 3.1% in November, recording the lowest reading in five months, compared to 3.2% in October.
Now Read This: <a href="https://www.benzinga.com/news/23/12/36195518/top-5-utilities-stocks-that-should-keep-you-up-at-night"> Top 5 Utilities Stocks That Should Keep You Up At Night</a>

Earnings

Eurozone

Commodities

Global

ACHV

ADTX

ICVX

ORCL

Crude Oil Down 4%; Aditxt Shares Spike Higher

Shares of Johnson Controls International plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jci#NYSE">JCI</a>) moved lower during Tuesday&rsquo;s session following <a href="https://www.benzinga.com/news/earnings/23/12/36196285/building-solutions-provider-johnson-controls-q4-results-fall-short-of-expectations-details">weak quarterly results.</a>
Johnson Controls reported fourth-quarter FY23 sales growth of 2.7% year-on-year to $6.91 billion (+2% organically), missing the consensus of $7.09 billion. Adjusted EPS of $1.05 (+6% Y/Y) below the consensus of $1.09, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Johnson Controls International shares fell 6.2% to $53.05 on Tuesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) shares jumped 140.5% to $9.14 after the company entered into definitive agreement to acquire Evofem Biosciences.</li>
<li>C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) gained 57.5% to $1.8590 after the company announced a license and research collaboration with Merck to discover and develop degrader-antibody conjugates.</li>
<li>Candel Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cadl#NASDAQ">CADL</a>) shares climbed 48% to $1.24 after the company announced it received FDA Fast Track Designation for CAN-2409 in pancreatic cancer.</li>
<li>Icosavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icvx#NASDAQ">ICVX</a>) rose climbed 47.1% to $15.43 after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion. Concurrently, Icosavax released topline interim results for its Phase 2 study of IVX-A12, a combination virus-like particle (VLP) vaccine candidate targeting both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).</li>
<li>Clean Earth Acquisitions Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clin#NASDAQ">CLIN</a>) gained 41.3% to $6.71. Clean Earth and Alternus Energy announced continuation of business combination close process.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) shares rose 24.1% to $0.2022 after gaining over 5% on Monday.</li>
<li>Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) gained 23.7% to $2.1286. Spectaire announced manufacturing financing agreement to enable mass production.</li>
<li>Gaotu Techedu Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gotu#NYSE">GOTU</a>) rose 18% to $3.4650.</li>
<li>IN8bio, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inab#NASDAQ">INAB</a>) gained 17.8% to $1.5080 after the company announced updated data from its Phase 1 investigator-sponsored trial of INB-100 in patients with hematologic malignancies.</li>
<li>Pineapple Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/papl#NYSE">PAPL</a>) rose 13.9% to $2.29.</li>
<li>Intchains Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/icg#NYSE">ICG</a>) gained 13.5% to $10.16.</li>
<li>Oil-Dri Corporation of America (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/odc#NYSE">ODC</a>) rose 12.2% to $66.09 following first-quarter results.</li>
<li>Hanryu Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hryu#NASDAQ">HRYU</a>) shares surged 11.2% to $0.70 after jumping 40% on Monday.</li>
<li>CAVA Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cava#NYSE">CAVA</a>) gained 9.8% to $35.68.</li>
<li>Eagle Bulk Shipping Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/egle#NYSE">EGLE</a>) jumped 9.2% to $50.42. Star Bulk and Eagle Bulk Shipping announced plans to combine.</li>
<li>Blue Bird Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blbd#NASDAQ">BLBD</a>) shares rose 9.1% to $23.80 after the company reported better-than-expected financial results for its fourth quarter and increased its FY24 revenue forecast.</li>
<li>Digital Turbine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apps#NASDAQ">APPS</a>) gained 7.8% to $6.58.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Achieve Life Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/achv#NASDAQ">ACHV</a>) shares fell 41.9% to $3.1686. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline. Oppenheimer maintained Achieve Life Sciences with an Outperform and lowered the price target from $21 to $18.</li>
<li>Boqii Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bq#NYSE">BQ</a>) fell 37.7% to $1.3824.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) declined 36.7% to $0.0962 as the company announced pricing of public offering.</li>
<li>SRIVARU Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svmh#NASDAQ">SVMH</a>) fell 30.3% to $0.4999 after jumping 20% on Monday.</li>
<li>Harbor Custom Development, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcdi#NASDAQ">HCDI</a>) fell 26.8% to $0.4975. Harbor Custom Development voluntarily filed for protection under Chapter 11 Bankruptcy.</li>
<li>Assure Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionm#NASDAQ">IONM</a>) shares fell 26% to $0.32 after climbing over 23% on Monday.</li>
<li>African Agriculture Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aagr#NASDAQ">AAGR</a>) declined 20% to $0.8747.</li>
<li>Adit EdTech Acquisition Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adex#NYSE">ADEX</a>) fell 17.7% to $6.05.</li>
<li>Nogin, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nogn#NASDAQ">NOGN</a>) fell 17.5% to $0.1402.</li>
<li>Bon Natural Life Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bon#NASDAQ">BON</a>) fell 17.1% to $0.4974.</li>
<li>Incannex Healthcare Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ixhl#NASDAQ">IXHL</a>) declined 11.2% to $4.4201.</li>
<li>Hempacco Co., Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hpco#NASDAQ">HPCO</a>) shares fell 11.1% to $0.3598.</li>
<li>Oracle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/orcl#NYSE">ORCL</a>) fell 10.3% to $103.32. Oracle reported upbeat earnings for its second quarter, while sales missed estimates.</li>
<li>Clean Energy Fuels Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clne#NASDAQ">CLNE</a>) dipped 10.1% to $3.2550.</li>
<li>Clearmind Medicine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmnd#NASDAQ">CMND</a>) fell 9.1% to $2.7650. Clearmind Medicine filed for mixed shelf of up to $50 million.</li>
<li>Lucid Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcid#NASDAQ">LCID</a>) shares fell 8.8% to $4.2050. Lucid Group disclosed that CFO Sherry House is resigning to pursue other opportunities.</li>
<li>Arcellx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aclx#NASDAQ">ACLX</a>) fell 8.7% to $47.79. Needham reiterated Arcellx with a Buy and maintained a $65 price target.</li>
<li>GoPro, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gpro#NASDAQ">GPRO</a>) declined 8.4% to $3.28. Morgan Stanley downgraded GoPro from Equal-Weight to Underweight and lowered the price target from $4 to $3.</li>
<li>SilverBow Resources, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbow#NYSE">SBOW</a>) dipped 7.7% to $27.65. SilverBow Resources announced the upsize and pricing of a previously announced underwritten public offering of its common by an affiliate of Strategic Value Partners, LLC.</li>
<li>Kinetik Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kntk#NYSE">KNTK</a>) shares fell 3.4% to $33.17. Kinetik reported the pricing of an upsized underwritten secondary offering of 6,500,000 shares of its Class A common stock by Apache Midstream LLC at a price of $31.50 per share.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/12/36196130/dont-miss-these-3-high-yielding-dividend-stocks-in-health-care-sector-from-wall-streets-most-accurat"> Don&#39;t Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street&#39;s Most Accurate Analysts</a>
&nbsp;

AAGR

ACLX

ADEX

APPS

BLBD

BRSH

CADL

CAVA

CLIN

CLNE

CMND

EGLE

GSX Techedu Inc. American Depositary Shares

GOTU

GPRO

HCDI

HPCO

IONM

IXHL

KNTK

LCID

NOGN

PAPL

SBOW

SPEC

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

U.S. stocks turned higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday.
The Dow traded up 0.35% to 36,533.63 while the NASDAQ rose 0.16% to 14,455.15 The S&amp;P 500 also rose, gaining, 0.10% to 4,627.04
Check This Out: <a href="https://www.benzinga.com/news/23/12/36192758/microsoft-u-s-bancorp-and-2-other-stocks-insiders-are-selling"> Microsoft, U.S. Bancorp And 2 Other Stocks Insiders Are Selling</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Industrials shares rose by 0.3% on Tuesday.
In trading on Tuesday, energy shares fell by 1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Oracle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/orcl#NYSE">ORCL</a>) reported upbeat earnings for its second quarter, while sales missed estimates.
Oracle reported quarterly adjusted earnings of $1.34 per share, topping the Street&#39;s estimate of $1.32. Revenue of $12.94 billion fell short of the analyst consensus estimate of $13.05 billion.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) shares shot up 78% to $6.76. Aditxt agreed to acquire Evofem Biosciences in consideration of the issuance of a combination of common stock and preferred stock and the assumption of certain senior indebtedness, having an aggregate amount of approximately $100 million.
Shares of C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) got a boost, surging 93% to $2.28. C4 Therapeutics entered into an exclusive license and collaboration agreement with Merck &amp; Co to develop degrader-antibody conjugates (DACs), an emerging modality designed to selectively target and neutralize disease-causing proteins in cancer cells.
Icosavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icvx#NASDAQ">ICVX</a>) shares were also up, gaining 48% to $15.51. AstraZeneca agreed to acquire Icosavax at $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Achieve Life Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/achv#NASDAQ">ACHV</a>) shares dropped 40% to $3.2697. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline. Oppenheimer maintained Achieve Life Sciences with an Outperform and lowered the price target from $21 to $18.
Shares of Harbor Custom Development, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcdi#NASDAQ">HCDI</a>) were down 26% to $0.5015. Harbor Custom Development voluntarily filed for protection under Chapter 11 Bankruptcy.
Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) was down, falling 40% to $0.0913 as the company announced pricing of public offering.
Also Check This Out:<a href="https://www.benzinga.com/news/23/12/36196130/dont-miss-these-3-high-yielding-dividend-stocks-in-health-care-sector-from-wall-streets-most-accurat"> Don&#39;t Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street&#39;s Most Accurate Analysts</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 2.5% to $69.52 while gold traded up 0.2% at $1,998.50.
Silver traded up 0.3% to $23.13 on Tuesday while copper rose 0.1% to $3.7850.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mixed today. The eurozone&rsquo;s STOXX 600 fell 0.21%, London&rsquo;s FTSE 100 rose 0.02% while Spain&rsquo;s IBEX 35 Index fell 0.63% The German DAX rose 0.01% French CAC 40 rose 0.06%, while Italy&rsquo;s FTSE MIB Index fell 0.07%.
The ZEW Indicator of Economic Sentiment for the Eurozone surged by 9.2 points to 23 in December, recording the strongest reading in ten months, while German ZEW Indicator of Economic Sentiment rose to 12.8 in December from 9.8 in November.
The number of job vacancies in the UK fell to 949,000 from September to November, while regular pay, excluding bonus payment in the UK, rose 7.3% year-over-year to GBP 620/week in the three months to October.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly higher on Tuesday, with Japan&rsquo;s Nikkei 225 gaining 0.16%, Hong Kong&rsquo;s Hang Seng Index gaining 1.07% and China&rsquo;s Shanghai Composite Index gaining 0.40%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell 0.54%.
Producer prices in Japan increased 0.3% year-over-year in November following a revised 0.9% rise in October.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NFIB Small Business Optimism Index declined for a fourth straight month to a reading of 90.6 in November.
The annual inflation rate in the U.S. eased to 3.1% in November, recording the lowest reading in five months, compared to 3.2% in October.
Now Read This: <a href="https://www.benzinga.com/news/23/12/36195518/top-5-utilities-stocks-that-should-keep-you-up-at-night"> Top 5 Utilities Stocks That Should Keep You Up At Night</a>

Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results

Green Giant Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) shares are trading lower by 36% to $0.098 Tuesday morning after the company&nbsp;announced a securities purchase agreement to sell units totaling <a href="https://www.benzinga.com/pressreleases/23/12/g36196484/green-giant-inc-announces-pricing-of-public-offering">$5.95 million</a>.
These units include common stock shares, Class A and Class B common warrants to purchase shares, and pre-funded units with respective warrants. The sale involves 35,000,000 units priced at $0.17 per unit.
The warrants have specific terms for exercise prices and conditions, with a provision for a shareholders&#39; meeting to increase the authorized share capital.
Maxim Group LLC is the sole placement agent for this offering, which is expected to close around December 14, 2023, pending customary closing conditions.
See Also:&nbsp;<a href="https://www.benzinga.com/news/econ-s/23/12/36195940/november-inflation-report-cpi-eases-to-3-1-annual-rate-ahead-of-fed-meeting" target="_blank">November Inflation Report</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, GGE has a 52-week high of $3.30 and a 52-week low of $0.09.

Why Green Giant (GGE) Stock Hit A New All-Time Low Today

WIIM

Green Giant shares are trading lower after the company announced pricing of its public offering.

Under the terms of the securities purchase agreement, GGE has agreed to sell 35,000,000 units at a per unit purchase price of $0.17. The Class A common warrants will be exercisable immediately upon the increase of the Company's authorized shares for a term of five years and have an initial exercise price of $0.17 subject to certain reset 30 trading days after the increase of the Company's authorized shares. The Class B common warrants will be exercisable immediately upon the date of issuance for a term of five years and have an initial exercise price of $0.27. In addition to the customary cashless exercise rights provided in both the Class A common warrants and the Class B common warrants, the Class B common warrants will also provide an alternate cashless exercise allowing the holder to right to exercise at any time, on a cashless exercise basis for a larger number of shares of common stock under certain conditions. The Company agreed to hold a shareholders' meeting within 120 days of closing of the Offering to increase the authorized share of common stock of the Company. The holders of the warrants agreed not to exercise cashlessly below $1.50 during the first 20 trading days after effectuation of a reverse split of the common stock.

Offerings

Green Giant Announces Pricing Of Public Offering; To Sell $5.95M Of Its Units; Agreed To Sell 35M Units At Per Unit Purchase Price Of $0.17

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Monday.
The Dow traded up 0.26% to 36,341.44 while the NASDAQ rose&nbsp;0.12% to 14,421.98. The S&amp;P 500 also rose, gaining, 0.30% to 4,618.11.
Check This Out: <a href="https://www.benzinga.com/news/23/12/36174228/this-analyst-with-84-accuracy-rate-sees-more-than-7-upside-in-broadcom-here-are-5-stock-picks-for-la"> This Analyst With 84% Accuracy Rate Sees More Than 7% Upside In Broadcom - Here Are 5 Stock Picks For Last Week From Wall Street&#39;s Most Accurate Analysts</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Industrials shares rose by 0.8% on Monday.
In trading on Monday, communication services shares fell by 1.5%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Macy&#39;s Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/m#NYSE">M</a>) shares jumped more than 20% on Monday following a report suggesting an investor group made a $5.8 billion buyout offer for the company.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Pasithea Therapeutics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktta#NASDAQ">KTTA</a>) shares shot up 92% to $0.59 after the company announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation cancer xenograft models.
Shares of MorphoSys AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mor#NASDAQ">MOR</a>) got a boost, surging 24% to $8.76 as the company presented comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib at 65th American Society of Hematology Annual Meeting.
The Cigna Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ci#NYSE">CI</a>) shares were also up, gaining 16% to $300.05. Cigna has withdrawn from its proposed merger with Humana Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hum#NYSE">HUM</a>).
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Cogent Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cogt#NASDAQ">COGT</a>) shares dropped 54% to $3.9993 after the company reported initial data from its ongoing Phase 2 SUMMIT trial and data from Part 1 of its ongoing Phase 2 APEX clinical at ASH 2023.
Shares of Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) were down 41% to $0.1510 after announcing a proposed public offering.
Near Intelligence, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nir#NASDAQ">NIR</a>) was down, falling 39% to $0.0926. Near Intelligence filed for Chapter 11 protection and entered into agreement to sell its business.
Also Check This Out:<a href="https://www.benzinga.com/news/23/12/36174321/alphabet-best-buy-and-2-other-stocks-insiders-are-selling"> Alphabet, Best Buy And 2 Other Stocks Insiders Are Selling</a>
&nbsp;
Commodities
In commodity news, oil traded down 0.8% to $70.65 while gold traded down 1% at $1,994.40.
Silver traded down 1% to $23.045 on Monday while copper fell 1.3% to $3.7810.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 rose 0.30%, London&rsquo;s FTSE 100 fell 0.13% while Spain&rsquo;s IBEX 35 Index fell 0.25% The German DAX gained 0.21% French CAC 40 gained 0.33%, while Italy&rsquo;s FTSE MIB Index rose 0.07%.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly higher on Monday, with Japan&rsquo;s Nikkei 225 gaining 1.50%, Hong Kong&rsquo;s Hang Seng Index falling 0.81% and China&rsquo;s Shanghai Composite Index gaining 0.74%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, rose 0.15%.
Japan&rsquo;s machine tool orders fell 13.6% year-over-year to JPY 115,884 million in November versus a 20.6% plunge in October. The business survey index of large manufacturing firms in Japan accelerated to 5.7% in the fourth quarter from 5.4% in the prior quarter.
China&#39;s producer prices fell by 3.0% year-over-year in November versus a 2.6% decline in the previous month, while consumer prices fell by 0.5% year-over-year in November.
&nbsp;
<h3>Economics</h3>
&nbsp;
There were no major US economic releases Monday.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36174159/top-5-tech-and-telecom-stocks-that-are-set-to-fly-in-q4"> Top 5 Tech And Telecom Stocks That Are Set To Fly In Q4</a>

COGT

KTTA

Morgan Stanley Capital Protected Notes for S&P 500 Index

Nasdaq Edges Higher; Macy's Shares Jump

Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) shares are trading lower by 40% to $0.15 Monday afternoon after the company initiated a public offering of units, each containing one share of common stock, along with Class A and Class B common warrants for <a href="https://www.benzinga.com/pressreleases/23/12/g36160884/green-giant-inc-announces-proposed-public-offering">purchasing additional shares</a>.
Green Giant itself is offering all the shares and warrants. The completion and specifics of the offering are subject to market conditions and other factors, with no guaranteed completion or defined terms at this stage.
Maxim Group LLC serves as the sole placement agent for this offering.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/asia/23/12/36172712/asia-markets-rise-europe-trades-mixed-while-crude-oil-hovers-near-70-global-markets-today-while-us-w">Asia Markets Rise, Europe Trades Mixed While Crude Oil Hovers Near $70</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, GGE has a 52-week high of $3.30 and a 52-week low of $0.15.

Why Green Giant (GGE) Shares Are Down 40%

Shares of bluebird bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blue#NASDAQ">BLUE</a>) rose sharply during Monday&rsquo;s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting &amp; Exposition.
bluebird bio shares rose 6.6% to $3.05 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Pasithea Therapeutics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktta#NASDAQ">KTTA</a>) shares jumped 142.6% to $0.7399 after the company announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation cancer xenograft models.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) shares climbed 79.4% to $0.7538 on continued volatility after the company last week received notification for not meeting the deadline to file its financial reports for several periods in 2023.</li>
<li>Jet.AI Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jtai#NASDAQ">JTAI</a>) climbed 66% to $2.7550. The company recently posted a narrower quarterly loss.</li>
<li>Assure Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionm#NASDAQ">IONM</a>) gained 69.9% to $0.5950.</li>
<li>Intchains Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icg#NASDAQ">ICG</a>) rose 25.8% to $11.02.</li>
<li>Professional Diversity Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipdn#NASDAQ">IPDN</a>) rose 23.3% to $2.64.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) gained 20% to $3.7450.</li>
<li>MorphoSys AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mor#NASDAQ">MOR</a>) rose 17.4% to $8.28 as the company presented comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib at 65th American Society of Hematology Annual Meeting.</li>
<li>The Cigna Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ci#NYSE">CI</a>) shares gained 16.8% to $302.25. Cigna has withdrawn from its proposed merger with</li>
<li>Humana Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hum#NYSE">HUM</a>).</li>
<li>Macy&#39;s, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/m#NYSE">M</a>) rose 16.4% to $20.24. An investor consortium has tabled a $5.8 billion bid to acquire Macy&#39;s, in an attempt to privatize the iconic department store chain.</li>
<li>Onconova Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ontx#NASDAQ">ONTX</a>) shares rose 15.6% to $0.7421. Onconova Therapeutics&#39; preclinical narazaciclib data at SABCS highlighted differentiated anti-tumor activity v. other CDK4/6i&#39;s.</li>
<li>Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) gained 14.7% to $3.50.</li>
<li>Conduit Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdt#NASDAQ">CDT</a>) rose 14% to $5.87.</li>
<li>Inhibikase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikt#NASDAQ">IKT</a>) climbed 13.8% to $1.40.</li>
<li>CommScope Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/comm#NASDAQ">COMM</a>) gained 13% to $2.0785. CommScope Holding SVP &amp; President, CCS Koen Linde Ter acquired a total of 13,513 shares at an average price of $1.84.</li>
<li>Blueprint Medicines Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpmc#NASDAQ">BPMC</a>) rose 8.2% to $80.07. Blueprint Medicines announced data showcasing its commitment to advance the scientific understanding and treatment of systemic mastocytosis was highlighted at 2023 ASH Annual Meeting.</li>
<li>Shake Shack Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shak#NYSE">SHAK</a>) gained 8.3% to $66.02. CEO Randy Garutti will retire from Shake Shack in 2024. The company also reiterated its fourth quarter and FY23 guidance.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Near Intelligence, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nir#NASDAQ">NIR</a>) fell 44.4% to $0.0845. Near Intelligence filed for Chapter 11 protection and entered into agreement to sell its business.</li>
<li>African Agriculture Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aagr#NASDAQ">AAGR</a>) fell 41.6% to $1.34 after dipping 49% on Friday.</li>
<li>Altamira Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyto#NASDAQ">CYTO</a>) fell 40.7% to $0.2430 after the company issued investor and business update. The company&#39;s board has decided to effect a 20-for-1 reverse stock split on Dec. 13, 2023.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) fell 40% to $0.1522 after announcing a proposed public offering.</li>
<li>Biomea Fusion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmea#NASDAQ">BMEA</a>) shares fell 32.2% to $11.40 after the company announced it presented data for BMF-219 in relapsed / refractory AML patients with menin-dependent mutations at the ASH 2023 Annual Meeting.</li>
<li>Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) declined 30% to $0.2344. Troika Media Group recently announced it filed for Chapter 11.</li>
<li>Veru Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veru#NASDAQ">VERU</a>) fell 29.1% to $0.83.</li>
<li>X4 Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xfor#NASDAQ">XFOR</a>) fell 25.6% to $0.6531. X4 Pharmaceuticals announced presentation of additional data from mavorixafor Phase 2 trial in chronic neutropenia at ASH 2023.</li>
<li>Cyngn Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) fell 24.5% to $0.1594. Cyngn shares fell 47% on Friday after the company announced pricing of a $5 million public offering of common stock.</li>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) shares fell 22.9% to $0.1460. RiskOn International recently said Kurt Flygare has been appointed Chief Executive Officer of GuyCare Management, Inc., a subsidiary of GuyCare, Inc.</li>
<li>Kodiak Sciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kod#NASDAQ">KOD</a>) fell 22.4% to $2.4501. Goldman Sachs reinstated Kodiak Sciences with a Sell and announced a $2 price target.</li>
<li>Vapotherm, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vapo#NYSE">VAPO</a>) dipped 22.3% to $1.53. Vapotherm revealed notification to NYSE of intention to voluntarily delist common stock application pending to transfer shares to OTCQX.</li>
<li>eFFECTOR Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eftr#NASDAQ">EFTR</a>) fell 17.1% to $0.4293. eFFECTOR Therapeutics, on Friday, announced new interim data from dose escalation and Phase 2 expansion cohorts of a Phase 1/2 study of zotatifin in patients with estrogen receptor positive (ER+) metastatic breast cancer.</li>
<li>Keros Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kros#NASDAQ">KROS</a>) declined 16% to $29.92. Keros Therapeutics showcased Phase 2 trials on blood disorders at ASH 2023.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) fell 15% to $1.5501.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) fell 12.9% to $9.00.</li>
<li>Gildan Activewear Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gil#NYSE">GIL</a>) declined 12.8% to $31.85. Gildan Activewear said Glenn J. Chamandy has left his position as President, CEO and Director.</li>
<li>iSun, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/isun#NASDAQ">ISUN</a>) shares fell 10.8% to $0.1712 after declining around 7% on Friday.</li>
<li>HIVE Digital Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hive#NASDAQ">HIVE</a>) declined 10.6% to $3.7550 amid a pullback in the price of Bitcoin.</li>
<li>Bit Digital, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btbt#NASDAQ">BTBT</a>) fell 10.6% to $3.1850 amid a pullback in the price of Bitcoin.</li>
<li>Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) dipped 10.5% to $14.16 amid a pullback in the price of Bitcoin.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) fell 9.9% to $15.12 amid a pullback in the price of Bitcoin.</li>
<li>Apellis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apls#NASDAQ">APLS</a>) dipped 9.2% to $56.96. Apellis said EMPAVELI (Pegcetacoplan) provided long-term control of PNH in new data presented at ASH Annual Meeting.</li>
<li>Zai Lab Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zlab#NASDAQ">ZLAB</a>) fell 6.8% to $25.40.</li>
<li>DISH Network Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dish#NASDAQ">DISH</a>) declined 5.4% to $4.3250.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/12/36171134/how-to-earn-500-a-month-from-vail-resorts-stock-after-q1-earnings-report"> How To Earn $500 A Month From Vail Resorts Stock After Q1 Earnings Report</a>

APLS

BLUE

BMEA

BPMC

BTBT

COMM

CYTO

DISH

DOGZ

EFTR

HIVE

ISUN

JTAI

KROS

MARA

MINM

ONTX

RIOT

SHAK

TRKA

VAPO

VERU

WULF

XFOR

ZLAB

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session